SPAC merg­er called off as com­pa­ny con­nect­ed to ex-Pur­due CEO de­cides to re­main pri­vate

Some­times, the third time is not the charm.

Blade Ther­a­peu­tics an­nounced Mon­day morn­ing that the com­pa­ny and its pro­posed merg­er part­ner, Biotech Ac­qui­si­tion Com­pa­ny, mu­tu­al­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER